---
title: Charles River Laboratories vs Oxford Biomedica
slug_a: criver
slug_b: oxb
site: cdmo
review_signal_gate: closed
canonical_path: /compare/criver/oxb
---

# Charles River Laboratories vs Oxford Biomedica

Side-by-side profile data from each company listing on this directory.

## Charles River Laboratories

- Profile: [/companies/criver](/companies/criver)

Charles River Laboratories — Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years.

Services: 21. Modalities: 6. Indications: 3. Locations: 7. Certifications: 5. The strongest documented coverage currently appears in services (21).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Microbial Fermentation
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Cell Therapy Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- AAV / Viral Vector Platform

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Expression: Mammalian
- Expression: Cell-Free
- Expression: Microbial
- Expression: Viral Vector
- Single-Use / Disposable
- Stainless Steel

## Oxford Biomedica

- Profile: [/companies/oxb](/companies/oxb)

Oxford Biomedica — Global viral vector CDMO with 30 years of expertise in lentivirus, AAV, and adenovirus manufacturing. Provides end-to-end development and GMP-compliant manufacturing services from preclinical through commercial launch for cell and gene therapy programs.

Services: 12. Modalities: 4. Indications: 3. Locations: 17. Certifications: 1. The strongest documented coverage currently appears in locations (17).

### Services

- Upstream Processing
- Downstream Processing
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Cell Therapy Manufacturing
- Vaccine Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Cell Therapy
- Gene Therapy
- Vaccine
- AAV / Viral Vector Platform

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Max bioreactor: Mid-scale clinical (≤2,000 L)
- Expression: Mammalian
- Expression: Cell-Free
- Expression: Viral Vector
- Single-Use / Disposable
- Stainless Steel